Painless and efficient ALA-PDT and MAL-PDT of actinic keratosis can be achieved by drastically reducing the drug-light interval

Dermatol Ther. 2020 May;33(3):e13423. doi: 10.1111/dth.13423. Epub 2020 Apr 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminolevulinic Acid / therapeutic use
  • Humans
  • Keratosis, Actinic* / diagnosis
  • Keratosis, Actinic* / drug therapy
  • Pharmaceutical Preparations*
  • Photochemotherapy*
  • Photosensitizing Agents / adverse effects
  • Treatment Outcome

Substances

  • Pharmaceutical Preparations
  • Photosensitizing Agents
  • Aminolevulinic Acid